Edwards Lifesciences Corp (EW)
92.85
+0.54
(+0.58%)
USD |
NYSE |
Mar 18, 16:00
92.89
+0.04
(+0.04%)
After-Hours: 20:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 55.83B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 15.00% |
Valuation | |
PE Ratio | 40.39 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 9.427 |
Price to Book Value | 8.399 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.0898 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 52.78% |
Profile
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US |
URL | https://www.edwards.com |
Investor Relations URL | https://ir.edwards.com/ |
HQ State/Province | California |
Sector | Healthcare |
Industry | Medical Devices |
Equity Style | Mid Cap/Blend |
Next Earnings Release | Apr. 26, 2024 (est.) |
Last Earnings Release | Feb. 06, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US |
URL | https://www.edwards.com |
Investor Relations URL | https://ir.edwards.com/ |
HQ State/Province | California |
Sector | Healthcare |
Industry | Medical Devices |
Equity Style | Mid Cap/Blend |
Next Earnings Release | Apr. 26, 2024 (est.) |
Last Earnings Release | Feb. 06, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |